ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Non-Opioid Pain Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-37U5878
Home | Market Reports | Health| Health Conditions| Pain Management
Global Non Opioid Pain Treatment Market Insights Forecast to 2028
BUY CHAPTERS

Global Non-Opioid Pain Treatment Market Research Report 2025

Code: QYRE-Auto-37U5878
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Allergan plc
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US WorldMeds, LLC

Non-Opioid Pain Treatment Market Size

The global market for Non-Opioid Pain Treatment was valued at US$ 26400 million in the year 2024 and is projected to reach a revised size of US$ 73680 million by 2031, growing at a CAGR of 16.0% during the forecast period.

Non-Opioid Pain Treatment Market

Non-Opioid Pain Treatment Market

Non-Opioid Pain Treatment address acute and chronic pain and regulatory issues faced by healthcare professionals.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Non-Opioid Pain Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Opioid Pain Treatment.
The Non-Opioid Pain Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Non-Opioid Pain Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-Opioid Pain Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Non-Opioid Pain Treatment Market Report

Report Metric Details
Report Name Non-Opioid Pain Treatment Market
Accounted market size in year US$ 26400 million
Forecasted market size in 2031 US$ 73680 million
CAGR 16.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Allergan PLC, Canopy Growth, Medical Marijuana Inc., Panag Pharma Inc., Tilray, Aphria Inc., Bedrocan, Cara Therapeutics, Centrexion Therapeutics, CHT Medical, Cronos Group, GW Pharmaceuticals, Medropharm Gmbh, US Worldmeds LLC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Non-Opioid Pain Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Non-Opioid Pain Treatment Market growing?

Ans: The Non-Opioid Pain Treatment Market witnessing a CAGR of 16.0% during the forecast period 2025-2031.

What is the Non-Opioid Pain Treatment Market size in 2031?

Ans: The Non-Opioid Pain Treatment Market size in 2031 will be US$ 73680 million.

Who are the main players in the Non-Opioid Pain Treatment Market report?

Ans: The main players in the Non-Opioid Pain Treatment Market are Allergan PLC, Canopy Growth, Medical Marijuana Inc., Panag Pharma Inc., Tilray, Aphria Inc., Bedrocan, Cara Therapeutics, Centrexion Therapeutics, CHT Medical, Cronos Group, GW Pharmaceuticals, Medropharm Gmbh, US Worldmeds LLC

What are the Application segmentation covered in the Non-Opioid Pain Treatment Market report?

Ans: The Applications covered in the Non-Opioid Pain Treatment Market report are Orthopaedic and Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Others

What are the Type segmentation covered in the Non-Opioid Pain Treatment Market report?

Ans: The Types covered in the Non-Opioid Pain Treatment Market report are Medical Cannabis Treatment, Capsaicin-derived Treatment, Menthol-containing Treatment, Omega 3 fatty acid-containing Treatment, Botulinum Toxins

Recommended Reports

Non-Opioid Pain Relief

Pain Management Expanded

Adjacent Therapeutic Markets

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Medical Cannabis Treatment
1.2.3 Capsaicin-derived Treatment
1.2.4 Menthol-containing Treatment
1.2.5 Omega 3 fatty acid-containing Treatment
1.2.6 Botulinum Toxins
1.3 Market by Application
1.3.1 Global Non-Opioid Pain Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Orthopaedic and Musculoskeletal Pain
1.3.3 Neuropathic Pain
1.3.4 Cancer Pain
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Non-Opioid Pain Treatment Market Perspective (2020-2031)
2.2 Global Non-Opioid Pain Treatment Growth Trends by Region
2.2.1 Global Non-Opioid Pain Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Non-Opioid Pain Treatment Historic Market Size by Region (2020-2025)
2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Region (2026-2031)
2.3 Non-Opioid Pain Treatment Market Dynamics
2.3.1 Non-Opioid Pain Treatment Industry Trends
2.3.2 Non-Opioid Pain Treatment Market Drivers
2.3.3 Non-Opioid Pain Treatment Market Challenges
2.3.4 Non-Opioid Pain Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2020-2025)
3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Non-Opioid Pain Treatment Revenue
3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2024
3.5 Global Key Players of Non-Opioid Pain Treatment Head office and Area Served
3.6 Global Key Players of Non-Opioid Pain Treatment, Product and Application
3.7 Global Key Players of Non-Opioid Pain Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Opioid Pain Treatment Breakdown Data by Type
4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2020-2025)
4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2026-2031)
5 Non-Opioid Pain Treatment Breakdown Data by Application
5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2020-2025)
5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Non-Opioid Pain Treatment Market Size (2020-2031)
6.2 North America Non-Opioid Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Non-Opioid Pain Treatment Market Size by Country (2020-2025)
6.4 North America Non-Opioid Pain Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Non-Opioid Pain Treatment Market Size (2020-2031)
7.2 Europe Non-Opioid Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Non-Opioid Pain Treatment Market Size by Country (2020-2025)
7.4 Europe Non-Opioid Pain Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2020-2031)
8.2 Asia-Pacific Non-Opioid Pain Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Non-Opioid Pain Treatment Market Size (2020-2031)
9.2 Latin America Non-Opioid Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Non-Opioid Pain Treatment Market Size by Country (2020-2025)
9.4 Latin America Non-Opioid Pain Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2020-2031)
10.2 Middle East & Africa Non-Opioid Pain Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Allergan PLC
11.1.1 Allergan PLC Company Details
11.1.2 Allergan PLC Business Overview
11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.1.5 Allergan PLC Recent Development
11.2 Canopy Growth
11.2.1 Canopy Growth Company Details
11.2.2 Canopy Growth Business Overview
11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.2.5 Canopy Growth Recent Development
11.3 Medical Marijuana Inc.
11.3.1 Medical Marijuana Inc. Company Details
11.3.2 Medical Marijuana Inc. Business Overview
11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.3.5 Medical Marijuana Inc. Recent Development
11.4 Panag Pharma Inc.
11.4.1 Panag Pharma Inc. Company Details
11.4.2 Panag Pharma Inc. Business Overview
11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.4.5 Panag Pharma Inc. Recent Development
11.5 Tilray
11.5.1 Tilray Company Details
11.5.2 Tilray Business Overview
11.5.3 Tilray Non-Opioid Pain Treatment Introduction
11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.5.5 Tilray Recent Development
11.6 Aphria Inc.
11.6.1 Aphria Inc. Company Details
11.6.2 Aphria Inc. Business Overview
11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.6.5 Aphria Inc. Recent Development
11.7 Bedrocan
11.7.1 Bedrocan Company Details
11.7.2 Bedrocan Business Overview
11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.7.5 Bedrocan Recent Development
11.8 Cara Therapeutics
11.8.1 Cara Therapeutics Company Details
11.8.2 Cara Therapeutics Business Overview
11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.8.5 Cara Therapeutics Recent Development
11.9 Centrexion Therapeutics
11.9.1 Centrexion Therapeutics Company Details
11.9.2 Centrexion Therapeutics Business Overview
11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.9.5 Centrexion Therapeutics Recent Development
11.10 CHT Medical
11.10.1 CHT Medical Company Details
11.10.2 CHT Medical Business Overview
11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.10.5 CHT Medical Recent Development
11.11 Cronos Group
11.11.1 Cronos Group Company Details
11.11.2 Cronos Group Business Overview
11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.11.5 Cronos Group Recent Development
11.12 GW Pharmaceuticals
11.12.1 GW Pharmaceuticals Company Details
11.12.2 GW Pharmaceuticals Business Overview
11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.12.5 GW Pharmaceuticals Recent Development
11.13 Medropharm Gmbh
11.13.1 Medropharm Gmbh Company Details
11.13.2 Medropharm Gmbh Business Overview
11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.13.5 Medropharm Gmbh Recent Development
11.14 US Worldmeds LLC
11.14.1 US Worldmeds LLC Company Details
11.14.2 US Worldmeds LLC Business Overview
11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2020-2025)
11.14.5 US Worldmeds LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Allergan plc
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US WorldMeds, LLC
List of Tables
 Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Medical Cannabis Treatment
 Table 3. Key Players of Capsaicin-derived Treatment
 Table 4. Key Players of Menthol-containing Treatment
 Table 5. Key Players of Omega 3 fatty acid-containing Treatment
 Table 6. Key Players of Botulinum Toxins
 Table 7. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Non-Opioid Pain Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Non-Opioid Pain Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Non-Opioid Pain Treatment Market Share by Region (2020-2025)
 Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Non-Opioid Pain Treatment Market Share by Region (2026-2031)
 Table 13. Non-Opioid Pain Treatment Market Trends
 Table 14. Non-Opioid Pain Treatment Market Drivers
 Table 15. Non-Opioid Pain Treatment Market Challenges
 Table 16. Non-Opioid Pain Treatment Market Restraints
 Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Non-Opioid Pain Treatment Market Share by Players (2020-2025)
 Table 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2024)
 Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Non-Opioid Pain Treatment, Headquarters and Area Served
 Table 23. Global Key Players of Non-Opioid Pain Treatment, Product and Application
 Table 24. Global Key Players of Non-Opioid Pain Treatment, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2020-2025)
 Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2026-2031)
 Table 30. Global Non-Opioid Pain Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2020-2025)
 Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2026-2031)
 Table 34. North America Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Non-Opioid Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Non-Opioid Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Non-Opioid Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Non-Opioid Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Non-Opioid Pain Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Non-Opioid Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Non-Opioid Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Allergan PLC Company Details
 Table 50. Allergan PLC Business Overview
 Table 51. Allergan PLC Non-Opioid Pain Treatment Product
 Table 52. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 53. Allergan PLC Recent Development
 Table 54. Canopy Growth Company Details
 Table 55. Canopy Growth Business Overview
 Table 56. Canopy Growth Non-Opioid Pain Treatment Product
 Table 57. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 58. Canopy Growth Recent Development
 Table 59. Medical Marijuana Inc. Company Details
 Table 60. Medical Marijuana Inc. Business Overview
 Table 61. Medical Marijuana Inc. Non-Opioid Pain Treatment Product
 Table 62. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 63. Medical Marijuana Inc. Recent Development
 Table 64. Panag Pharma Inc. Company Details
 Table 65. Panag Pharma Inc. Business Overview
 Table 66. Panag Pharma Inc. Non-Opioid Pain Treatment Product
 Table 67. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 68. Panag Pharma Inc. Recent Development
 Table 69. Tilray Company Details
 Table 70. Tilray Business Overview
 Table 71. Tilray Non-Opioid Pain Treatment Product
 Table 72. Tilray Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 73. Tilray Recent Development
 Table 74. Aphria Inc. Company Details
 Table 75. Aphria Inc. Business Overview
 Table 76. Aphria Inc. Non-Opioid Pain Treatment Product
 Table 77. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 78. Aphria Inc. Recent Development
 Table 79. Bedrocan Company Details
 Table 80. Bedrocan Business Overview
 Table 81. Bedrocan Non-Opioid Pain Treatment Product
 Table 82. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 83. Bedrocan Recent Development
 Table 84. Cara Therapeutics Company Details
 Table 85. Cara Therapeutics Business Overview
 Table 86. Cara Therapeutics Non-Opioid Pain Treatment Product
 Table 87. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 88. Cara Therapeutics Recent Development
 Table 89. Centrexion Therapeutics Company Details
 Table 90. Centrexion Therapeutics Business Overview
 Table 91. Centrexion Therapeutics Non-Opioid Pain Treatment Product
 Table 92. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 93. Centrexion Therapeutics Recent Development
 Table 94. CHT Medical Company Details
 Table 95. CHT Medical Business Overview
 Table 96. CHT Medical Non-Opioid Pain Treatment Product
 Table 97. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 98. CHT Medical Recent Development
 Table 99. Cronos Group Company Details
 Table 100. Cronos Group Business Overview
 Table 101. Cronos Group Non-Opioid Pain Treatment Product
 Table 102. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 103. Cronos Group Recent Development
 Table 104. GW Pharmaceuticals Company Details
 Table 105. GW Pharmaceuticals Business Overview
 Table 106. GW Pharmaceuticals Non-Opioid Pain Treatment Product
 Table 107. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 108. GW Pharmaceuticals Recent Development
 Table 109. Medropharm Gmbh Company Details
 Table 110. Medropharm Gmbh Business Overview
 Table 111. Medropharm Gmbh Non-Opioid Pain Treatment Product
 Table 112. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 113. Medropharm Gmbh Recent Development
 Table 114. US Worldmeds LLC Company Details
 Table 115. US Worldmeds LLC Business Overview
 Table 116. US Worldmeds LLC Non-Opioid Pain Treatment Product
 Table 117. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2020-2025) & (US$ Million)
 Table 118. US Worldmeds LLC Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Non-Opioid Pain Treatment Picture
 Figure 2. Global Non-Opioid Pain Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Non-Opioid Pain Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Medical Cannabis Treatment Features
 Figure 5. Capsaicin-derived Treatment Features
 Figure 6. Menthol-containing Treatment Features
 Figure 7. Omega 3 fatty acid-containing Treatment Features
 Figure 8. Botulinum Toxins Features
 Figure 9. Global Non-Opioid Pain Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Non-Opioid Pain Treatment Market Share by Application: 2024 VS 2031
 Figure 11. Orthopaedic and Musculoskeletal Pain Case Studies
 Figure 12. Neuropathic Pain Case Studies
 Figure 13. Cancer Pain Case Studies
 Figure 14. Others Case Studies
 Figure 15. Non-Opioid Pain Treatment Report Years Considered
 Figure 16. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global Non-Opioid Pain Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Non-Opioid Pain Treatment Market Share by Region: 2024 VS 2031
 Figure 19. Global Non-Opioid Pain Treatment Market Share by Players in 2024
 Figure 20. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2024
 Figure 22. North America Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America Non-Opioid Pain Treatment Market Share by Country (2020-2031)
 Figure 24. United States Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Non-Opioid Pain Treatment Market Share by Country (2020-2031)
 Figure 28. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Non-Opioid Pain Treatment Market Share by Region (2020-2031)
 Figure 36. China Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Non-Opioid Pain Treatment Market Share by Country (2020-2031)
 Figure 44. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Non-Opioid Pain Treatment Market Share by Country (2020-2031)
 Figure 48. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE Non-Opioid Pain Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 52. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 53. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 54. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 55. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 56. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 57. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 58. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 59. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 60. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 61. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 62. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 63. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 64. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Non Opioid Pain Relief Device Market Research Report 2024
Global Postoperative Pain Therapeutics Market Insights Forecast to 2030
Global Non opioid Analgesics Market Research Report 2024
Global Drugs for Pain Management Market Insights Forecast to 2030
Global Nonsurgical Rhinoplasty Market Insights Forecast to 2030
Global Non Narcotic Analgesics Market Research Report 2025
Global Non opioid Pain Patches Market Research Report 2024
Global Pain Management EMR Software Market Insights Forecast to 2030
Global Non surgical Operation Medical Cosmetology Market Insights Forecast to 2030
Global Pain Treatment Medication Market Research Report 2025
Global Nonnarcotic Analgesics Market Research Report 2025
Non opioid Pain Med Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pain Treatment Drug Market Research Report 2025
Global Pets Pain Management Market Insights Forecast to 2030
Global Cold Treatment Drug Market Insights Forecast to 2030
Global Drugs for Osteoarthritis Pain Market Insights Forecast to 2030
Global Pain Management and Surgical Devices Market Insights Forecast to 2030
Global Pain Management Drugs Market Research Report 2025
Global Chronic Pain Treatment Market Insights Forecast to 2030
Global Burn Therapy Market Insights Forecast to 2030

RELATED REPORTS

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0I20198
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Fentanyl Transdermal Patches Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6E8391
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Knee Pain Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18L1859
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Peripheral Neuropathy Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-17R6157
Fri Sep 05 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions